Green factories for biopharmaceuticals

Current Medicinal Chemistry

Volumn 20, Issue 8, 2013, Pages 1038-1046

  Melnik, S ^a   Stoger, E ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Molecular farming; Plant bioreactors; Plant prudued proteins; Recombinant pharmaceuticals

Indexed keywords

ABCIXIMAB; CERTOLIZUMAB PEGOL; GLYCAN DERIVATIVE; GLYCOPROTEIN; HUMAN GROWTH HORMONE; IMIGLUCERASE; N ACETYL BETA GLUCOSAMINIDASE; RANIBIZUMAB; RECOMBINANT BLOOD CLOTTING FACTOR 9; RECOMBINANT CYTOKINE; RECOMBINANT PROTEIN; TALIGLUCERASE ALFA; VEGETABLE PROTEIN;

ANTIBODY PRODUCTION; ARTICLE; BATCH PROCESS; BIOREACTOR; CYTOKINE RELEASE; DRUG APPROVAL; DRUG COST; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG SAFETY; ECONOMICS; ENDOPLASMIC RETICULUM; ENZYME SYNTHESIS; FOOD AND DRUG ADMINISTRATION; GAUCHER DISEASE; GLYCOSYLATION; GOLGI COMPLEX; GREEN FACTORY; HARVEST; HUMAN; IMMUNOGENICITY; LARGE SCALE PRODUCTION; MEDICINAL PLANT; MICROENVIRONMENT; MOLECULAR FARMING; NONHUMAN; PHARMACEUTICS; PLANT CELL; PLANT SEED; PROTEIN FOLDING; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; STREPTOCOCCUS MUTANS; VACCINE PRODUCTION; VIRUS LIKE AGENT;

EID: 84877999567     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986713805288879     Document Type: Article

References (119)

1. Walsh, G. Biopharmaceutical benchmarks 2010. Nat. Biotechnol., 2010, 28, 917-24.
2. Ma, J.K.; Drake, P.M.; Christou, P. The production of recombinant pharmaceutical proteins in plants. Nat. Rev. Genet., 2003, 4, 794-805. (Pubitemid 37193271)
3. Twyman, R.M.; Stoger, E.; Schillberg, S.; Christou, P.; Fischer, R. Molecular farming in plants: host systems and expression technology. Trends Biotechnol., 2003, 21, 570-8. (Pubitemid 37415010)
4. Lerouge. P.; Cabanes-Macheteau, M.; Rayon, C.; Fischette-Lainé, A.C.; Gomord, V.; Faye, L. N-glycoprotein biosynthesis in plants: recent developments and future trends. Plant Mol. Biol., 1998, 38, 31-48. (Pubitemid 28403765)
5. Gomord, V.; Fitchette, A.C.; Menu-Bouaouiche, L.; Saint-Jore-Dupas, C.; Plasson, C.; Michaud, D.; Faye, L. Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnol. J., 2010, 8, 564-87.
6. Rice, K.G.; Lee, Y.C. Oligosaccharide valency and conformation in determining binding to the asialoglycoprotein receptor of rat hepatocytes. Adv. Enzymol. Relat. Areas Mol. Biol., 1993, 66, 41-83.
7. Weise, A.; Altmann, F.; Rodriguez-Franco, M.; Sjoberg, E.R.; Bäumer, W.; Launhardt, H.; Kietzmann, M.; Gorr, G. High-level expression of secreted complex glycosylated recombinant human erythropoietin in the Physcomitrella Delta-fuc-T Delta-xyl-T mutant. Plant Biotechnol. J., 2007, 5, 389-401. (Pubitemid 46558324)
8. Drakakaki, G.; Marcel, S.; Arcalis, E.; Altmann, F.; Gonzalez-Melendi, P.; Fischer, R.; Christou, P.; Stoger, E. The intracellular fate of a recombinant protein is tissue dependent. Plant Physiol., 2006, 141, 578-86. (Pubitemid 43974552)
9. Arcalis, E.; Stadlmann, J.; Marcel, S.; Drakakaki, G.; Winter, V.; Rodriguez, J.; Fischer, R.; Altmann, F.; Stoger, E. The changing fate of a secretory glycoprotein in developing maize endosperm. Plant Physiol., 2010, 153, 693-702.
10. Gomord, V.; Denmat, L.A.; Fitchette-Lainé, A.C.; Satiat-Jeunemaitre, B.; Hawes, C.; Faye, L. The C-Terminal HDEL sequence is sufficient for retention of secretory proteins in the endoplasmic reticulum (ER) but promotes vacuolar targeting of proteins that escape the ER. Plant J., 1997, 11, 313-25. (Pubitemid 27147977)
11. Pagny, S.; Cabanes-Macheteau, M.; Gillikin, J.W.; Leborgne-Castel, N.; Lerouge, P.; Boston, R.S.; Faye, L.; Gomord, V. Protein recycling from the Golgi apparatus to the endoplasmic reticulum in plants and its minor contribution to calreticulin retention. Plant Cell, 2000, 12, 739-56.
12. Ko, K.; Tekoah, Y.; Rudd, P.M.; Harvey, D.J.; Dwek, R.A.; Spitsin, S.; Hanlon, C.A.; Rupprecht, C.; Dietzschold, B.; Golovkin, M.; Koprowski, H. Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc. Natl. Acad. Sci. USA, 2003, 100, 8013-8. (Pubitemid 36760086)
13. Wright, A.; Morrison, S.L. Effect of C2-Associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells. J. Immunol., 1998, 160, 3393-402. (Pubitemid 28164732)
14. Goetze, A.M.; Liu, Y.D.; Zhang, Z.; Shah, B.; Lee, E.; Bondarenko, P.V.; Flynn, G.C. High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans. Glycobiology, 2011, 21, 949-59.
15. Haddley, K. Taliglucerase alfa for the treatment of Gaucher's disease. Drugs Today (Barc), 2012, 48, 525-32.
16. Bosch, D.; Schots, A. Plant glycans: friend or foe in vaccine development? Expert. Rev. Vaccines, 2010, 9, 835-42.
17. Strasser, R.; Stadlmann, J.; Schähs, M.; Stiegler, G.; Quendler, H.; Mach, L.; Glössl, J.; Weterings, K.; Pabst, M.; Steinkellner, H. Generation of glycoengineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol. J., 2008, 6, 392-402. (Pubitemid 351490228)
18. Cox, K.M.; Sterling, J.D.; Regan, J.T.; Gasdaska, J.R.; Frantz, K.K.; Peele, C.G.; Black, A.; Passmore, D.; Moldovan-Loomis, C.; Srinivasan, M.; Cuison, S.; Cardarelli, P.M.; Dickey, L.F. Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat. Biotechnol., 2006, 24, 1591-7. (Pubitemid 44967485)
19. Toyoda, T.; Itai, T.; Arakawa, T.; Aoki, K.H.; Yamaguchi, H. Stabilization of human recombinant erythropoietin through interactions with the highly branched N-glycans. J. Biochem., 2000, 128, 731-7.
20. Castilho, A.; Gattinger, P.; Grass, J.; Jez, J.; Pabst, M.; Altmann, F.; Gorfer, M.; Strasser, R.; Steinkellner, H. N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex Nglycans. Glycobiology, 2011, 21, 813-23.
21. Castilho, A.; Strasser, R.; Stadlmann, J.; Grass, J.; Jez, J.; Gattinger, P.; Kunert, R.; Quendler, H.; Pabst, M.; Leonard, R.; Altmann F, Steinkellner H. In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol Chem, 2010; 285: 15923-30.
22. Daskalova, S.M.; Radder, J.E.; Cichacz, Z.A.; Olsen, S.H.; Tsaprailis, G.; Mason, H.; Lopez, L.C. Engineering of N. benthamiana L. plants for production of N-Acetylgalactosamine-glycosylated proteins-Towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation. BMC Biotechnol., 2010, 10, 62.
23. Yang, Z.; Drew, D.P.; Jørgensen, B.; Mandel, U.; Bach, S.S.; Ulvskov, P.; Levery, S.B.; Bennett, E.P.; Clausen, H.; Petersen, B.L. Engineering mammalian mucin-Type O-glycosylation in plants. J. Biol. Chem., 2012, 287, 11911-23.
24. Yang, Z.; Bennett, E.P.; Jørgensen, B.; Drew, D.P.; Arigi, E.; Mandel, U.; Ulvskov, P.; Levery, S.B.; Clausen, H.; Petersen, B.L. Towards Stable Genetic Engineering of Human O-glycosylation in Plants. Plant Physiol., 2012, 160(1), 450-63.
25. Oey, M.; Lohse, M.; Kreikemeyer, B.; Bock, R. Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic. Plant J., 2009, 57, 436-45.
26. Glenz, K.; Bouchon, B.; Stehle, T.; Wallich, R.; Simon, M.M.; Warzecha, H. Production of a recombinant bacterial lipoprotein in higher plant chloroplasts. Nat. Biotechnol., 2006, 24, 76-7. (Pubitemid 43083169)
27. Twyman, R.M.; Schillberg, S.; Fischer, R. Transgenic plants in the biopharmaceutical market. Expert. Opin. Emerg. Drugs, 2005, 10, 185-218. (Pubitemid 40293078)
28. Faye, L.; Gomord, V. Success stories in molecular farming-A brief overview. Plant Biotechnol. J., 2010, 8, 525-8.
29. Fischer, R.; Schillberg, S.; Hellwig, S.; Twyman, R.M.; Drossard, J. GMP issues for recombinant plant-derived pharmaceutical proteins. Biotechnol. Adv., 2012, 30, 434-9.
30. Hiatt, A.; Cafferkey, R.; Bowdish, K. Production of antibodies in transgenic plants. Nature, 1989, 342, 76-8.
31. Stoger, E.; Sack, M.; Nicholson, L.; Fischer, R.; Christou, P. Recent progress in plantibody technology. Curr. Pharm. Des., 2005, 11, 2439-57. (Pubitemid 40872689)
32. De Muynck, B.; Navarre, C.; Boutry, M. Production of antibodies in plants: status after twenty years. Plant Biotechnol. J., 2010, 8, 529-63.
33. Ma, J.K.; Lehner, T.; Stabila, P.; Fux, C.I.; Hiatt, A. Assembly of monoclonal antibodies with IgG1 and IgA heavy chain domains in transgenic tobacco plants. Eur. J. Immunol., 1994, 24, 131-8. (Pubitemid 24014688)
34. Ma, J.K.; Hikmat, B.Y.; Wycoff, K.; Vine, N.D.; Chargelegue, D.; Yu, L.; Hein, M.B.; Lehner, T. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat. Med., 1998, 4, 601-6. (Pubitemid 28237360)
35. EUDAMED European Databank on Medical Devices, 2012, (http://ec.europa.eu/ consumers/sectors/medical-devices/market-surveillancevigilance/eudamed/)
36. Peters, J.; Stoger, E. Transgenic crops for the production of recombinant vaccines and anti-microbial antibodies. Hum. Vaccin., 2011, 7, 367-74.
37. Menkhaus, T.J.; Bai, Y.; Zhang, C.; Nikolov, Z.L.; Glatz, C.E. Considerations for the recovery of recombinant proteins from plants. Biotechnol. Prog., 2004, 20, 1001-14. (Pubitemid 39059612)
38. McLean, M.D.; Chen, R.; Yu, D.; Mah, K.Z.; Teat, J.; Wang, H.; Zaplachinski, S.; Boothe, J.; Hall, J.C. Purification of the therapeutic antibody trastuzumab from genetically modified plants using safflower Protein A-oleosin oilbody technology. Transgenic Res., 2012, 21(6),1291-301.
39. Hussack, G.; Grohs, B.M.; Almquist, K.C.; McLean, M.D.; Ghosh, R.; Hall, J.C. Purification of plant-derived antibodies through direct immobilization of affinity ligands on cellulose. J. Agric Food Chem., 2010, 58, 3451-9.
40. Firek, S.; Draper, J.; Owen, M.R.; Gandecha, A.; Cockburn, B.; Whitelam, G.C. Secretion of a functional single-chain Fv protein in transgenic tobacco plants and cell suspension cultures. Plant Mol. Biol., 1993, 23, 861-70. (Pubitemid 2021254)
41. Wongsamuth, R.; Doran, P.M. Production of monoclonal antibodies by tobacco hairy roots. Biotechnol. Bioeng., 1997, 54, 401-15. (Pubitemid 27200313)
42. Drake, P.M.; Chargelegue, D.M.; Vine, N.D.; van Dolleweerd, C.J.; Obregon, P.; Ma, J.K. Rhizosecretion of a monoclonal antibody protein complex from transgenic tobacco roots. Plant Mol. Biol., 2003, 52, 233-41. (Pubitemid 36708417)
43. Chen Q, Lai H. Plant-derived virus-like particles as vaccines. Hum. Vaccin. Immunother., 2012, 9.
44. Hefferon, K.L. Plant virus expression vectors set the stage as production platforms for biopharmaceutical proteins. Virology, 2012, 433, 1-6.
45. Canizares, M.C.; Lomonossoff, G.P.; Nicholson, L. Development of cowpea mosaic virus-based vectors for the production of vaccines in plants. Expert. Rev. Vaccines, 2005, 4, 687-97. (Pubitemid 41530592)
46. Lavelle, E.C.; Grant, G.; Pfuller, U.; O'Hagan, D.T. Immunological implications of the use of plant lectins for drug and vaccine targeting to the gastrointestinal tract. J. Drug Target, 2004, 12, 89-95. (Pubitemid 38786917)
47. Kim, T.G.; Kim, M.Y.; Kim, B.G.; Kang, T.J.; Kim, Y.S.; Jang, Y.S.; Arntzen, C.J.; Yang, M.S. Synthesis and assembly of Escherichia coli heatlabile enterotoxin B subunit in transgenic lettuce (Lactuca sativa). Protein Expr. Purif., 2007, 51, 22-7. (Pubitemid 44821857)
48. Granell, A.; Fernández del-Carmen, A.; Orzáez, D. In planta production of plant-derived and non-plant-derived adjuvants. Expert. Rev. Vaccines, 2010, 9, 843-58.
49. Girard, A.; Saron, W.; Bergeron-Sandoval, L.P.; Sarhan, F.; Archambault, D. Flagellin produced in plants is a potent adjuvant for oral immunization. Vaccine, 2011, 29, 6695-703.
50. Pniewski, T.; Kapusta, J.; Bocig, P.; Wojciechowicz, J.; Kostrzak, A.; Gdula, M.; Fedorowicz-Stroska, O.; Wójcik, P.; Otta, H.; Samardakiewicz, S.; Wolko, B.; P-ucienniczak, A. Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablet formulation. J. Appl. Genet., 2011, 52, 125-36.
51. Lou, X.M.; Yao, Q.H.; Zhang, Z.; Peng, R.H.; Xiong, A.S.; Wang, H.K. Expression of the human hepatitis B virus large surface antigen gene in transgenic tomato plants. Clin. Vaccine Immunol., 2007, 14, 464-9. (Pubitemid 46732558)
52. Thanavala, Y.; Yang, Y.F.; Lyons, P.; Mason, H.S.; Arntzen, C. Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA, 1995, 92, 3358-61.
53. Thanavala, Y.; Mahoney, M.; Pal, S.; Scott, A.; Richter, L.; Natarajan, N.; Goodwin, P.; Arntzen, C.J.; Mason, H.S. Immunogenicity in humans of an edible vaccine for hepatitis B. Proc. Natl. Acad. Sci. USA, 2005, 102, 3378-82. (Pubitemid 40328053)
54. Shulga, N.Y.; Rukavtsova, E.B.; Krymsky, M.A.; Borisova, V.N.; Melnikov, V.A.; Bykov, V.A.; Buryanov, Y.I. Expression and characterization of hepatitis B surface antigen in transgenic potato plants. Biochemistry (Mosc), 2004, 69, 1158-64.
55. Kumar, G.B.; Ganapathi, T.R.; Revathi, C.J.; Srinivas, L.; Bapat, V.A. Expression of hepatitis B surface antigen in transgenic banana plants. Planta, 2005, 222, 484-93. (Pubitemid 41443647)
56. Pniewski, T.; Kapusta, J.; Bocig, P.; Kostrzak, A.; Fedorowicz-Stroska, O.; Czy, M.; Gdula, M.; Krajewski, P.; Wolko, B.; P-ucienniczak, A. Plant expression, lyophilisation and storage of HBV medium and large surface antigens for a prototype oral vaccine formulation. Plant Cell Rep., 2012, 31, 585-95.
57. Tanaka, Y.; Hayashida, S.; Hongo, M. The relationship of the feces protein particles to rice protein bodies. Agric. Biol. Chem., 1975, 39, 515-519.
58. Tanaka, Y.; Resurreccion, A.P.; Juriano, B.O.; Bechtel, D.B. Properties of whole and undigested fraction of protein bodies of milled rice. Agric. Biol. Chem., 1978, 42, 2015-2023.
59. Takaiwa, F. Seed-based oral vaccines as allergen-specific immunotherapies. Hum. Vaccin, 2011, 7, 357-66.
60. Hayden, C.A.; Egelkrout, E.M.; Moscoso, A.M.; Enrique, C.; Keener, T.K.; Jimenez-Flores, R.; Wong, J.C.; Howard, J.A. Production of highly concentrated, heat-stable hepatitis B surface antigen in maize. Plant Biotechnol. J., 2012, 10(8), 979-84.
61. Loza-Rubio, E.; Rojas-Anaya, E.; López, J.; Olivera-Flores, M.T.; Gómez-Lim, M.; Tapia-Pérez, G. Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein. Vaccine, 2012, 30, 5551-6.
62. Khan, I.; Twyman, R.M.; Arcalis, E.; Stoger, E. Using storage organelles for the accumulation and encapsulation of recombinant proteins. Biotechnol. J., 2012, 7(9), 1099-108
63. Marillonnet, S.; Thoeringer, C.; Kandzia, R.; Klimyuk, V.; Gleba, Y. Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nat. Biotechnol., 2005, 23, 718-23. (Pubitemid 41716362)
64. Kwak, L.W.; Campbell, M.J.; Czerwinski, D.K.; Hart, S.; Miller, R.A.; Levy, R. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl. J. Med., 1992, 327, 1209-15.
65. Hsu, F.J.; Caspar, C.B.; Czerwinski, D.; Kwak, L.W.; Liles, T.M.; Syrengelas, A.; Taidi-Laskowski, B.; Levy, R. Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma-long-Term results of a clinical trial. Blood, 1997, 89, 3129-35.
66. Bendandi, M.; Gocke, C.D.; Kobrin, C.B.; Benko, F.A.; Sternas, L.A.; Pennington, R.; Watson, T.M.; Reynolds, C.W.; Gause, B.L.; Duffey, P.L.; Jaffe, E.S.; Creekmore, S.P.; Longo, D.L.; Kwak, L.W. Complete molecular remissions induced by patient-specific vaccination plus granulocytemonocyte colony-stimulating factor against lymphoma. Nat. Med., 1999, 5, 1171-7. (Pubitemid 29474422)
67. McCormick, A.A. Tobacco derived cancer vaccines for non-Hodgkin's lymphoma: perspectives and progress. Hum. Vaccin., 2011, 7, 305-12.
68. Delorme, E.; Lorenzini, T.; Giffin, J.; Martin, F.; Jacobsen, F.; Boone, T.; Elliott, S. Role of glycosylation on the secretion and biological activity of erythropoietin. Biochemistry, 1992, 31, 9871-6.
69. Runkel, L.; Meier, W.; Pepinsky, R.B.; Karpusas, M.; Whitty, A.; Kimball, K.; Brickelmaier, M.; Muldowney, C.; Jones, W.; Goelz, S.E. Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta). Pharm. Res., 1998, 15, 641-9. (Pubitemid 28214960)
70. Banks, R.E.; Forbes, M.A.; Patel, P.M.; Storr, M.; Hallam, S.; Clarke, D.; Novick, D.; Ingham, E.; Bowmer, C.; Southgate, J.; Trejdosiewicz, L.K.; Illingworth, J.; Perren, T.J.; Selby, P.J. Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effects. Cytokine, 2000, 12, 388-96. (Pubitemid 30449831)
71. Dela Cruz, C.S.; Lee, Y.; Viswanathan, S.R.; El-Guindy, A.S.; Gerlach, J.; Nikiforow, S.; Shedd, D.; Gradoville, L.; Miller, G. N-linked glycosylation is required for optimal function of Kaposi's sarcoma herpesvirus-encoded, but not cellular, interleukin 6. J. Exp. Med., 2004, 199, 503-14. (Pubitemid 38233834)
72. Fuson, K.L.; Zheng, M.; Craxton, M.; Pataer, A.; Ramesh, R.; Chada, S.; Sutton, R.B. Structural mapping of post-Translational modifications in human interleukin-24: role of N-linked glycosylation and disulfide bonds in secretion and activity. J. Biol. Chem., 2009, 284, 30526-33.
73. Edelbaum, O.; Stein, D.; Holland, N.; Gafni, Y.; Livneh, O.; Novick, D.; Rubinstein, M.; Sela, I. Expression of active human interferon-beta in transgenic plants. J. Interferon Res., 1992, 12, 449-53. (Pubitemid 23002883)
74. Magnuson, N.S.; Linzmaier, P.M.; Reeves, R.; An, G.; HayGlass, K.; Lee, J.M. Secretion of biologically active human interleukin-2 and interleukin-4 from genetically modified tobacco cells in suspension culture. Protein Expr. Purif., 1998, 13, 45-52. (Pubitemid 28360345)
75. Patel, J.; Zhu, H.; Menassa, R.; Gyenis, L.; Richman, A.; Brandle, J. Elastinlike polypeptide fusions enhance the accumulation of recombinant proteins in tobacco leaves. Transgenic Res., 2007, 16, 239-49. (Pubitemid 46440610)
76. Bortesi, L.; Rossato, M.; Schuster, F.; Raven, N.; Stadlmann, J.; Avesani, L.; Falorni, A.; Bazzoni, F.; Bock, R.; Schillberg, S.; Pezzotti, M. Viral and murine interleukin-10 are correctly processed and retain their biological activity when produced in tobacco. BMC Biotechnol., 2009, 9, 22.
77. Kwon, T.H.; Seo, J.E.; Kim, J.; Lee, J.H.; Jang, Y.S.; Yang, M.S. Expression and secretion of the heterodimeric protein interleukin-12 in plant cell suspension culture. Biotechnol. Bioeng., 2003, 81, 870-5. (Pubitemid 36313726)
78. Gutiérrez-Ortega, A.; Avila-Moreno, F.; Saucedo-Arias, L.J.; Sánchez-Torres, C.; Gómez-Lim, M.A. Expression of a single-chain human interleukin-12 gene in transgenic tobacco plants and functional studies. Biotechnol. Bioeng., 2004, 85, 734-40. (Pubitemid 38332409)
79. Wang, D.J.; Brandsma, M.; Yin, Z.; Wang, A.; Jevnikar, A.M.; Ma, S. A novel platform for biologically active recombinant human interleukin-13 production. Plant Biotechnol. J., 2008, 6, 504-15. (Pubitemid 351670276)
80. Zhang, B.; Yang, Y.H.; Lin, Y.M.; Rao, Q.; Zheng, G.G.; Wu, K.F. Expression and production of bioactive human interleukin-18 in transgenic tobacco plants. Biotechnol. Lett., 2003, 25, 1629-35. (Pubitemid 37189967)
81. Matsumoto, S.; Ikura, K.; Ueda, M.; Sasaki, R. Characterization of a human glycoprotein (erythropoietin) produced in cultured tobacco cells. Plant Mol. Biol., 1995, 27, 1163-72.
82. James, E.A.; Wang, C.; Wangm Z.; Reeves, R.; Shin, J.H.; Magnuson, N.S.; Lee, J.M. Production and characterization of biologically active human GMCSF secreted by genetically modified plant cells. Protein Expr. Purif., 2000, 19, 131-8. (Pubitemid 30387904)
83. Sardana, R.K.; Alli, Z.; Dudani, A.; Tackaberry, E.; Panahi, M.; Narayanan, M.; Ganz, P.; Altosaar, I. Biological activity of human granulocytemacrophage colony stimulating factor is maintained in a fusion with seed glutelin peptide. Transgenic Res., 2002, 11, 521-31. (Pubitemid 35255182)
84. Ohya, K.; Matsumura, T.; Ohashi, K.; Onuma, M.; Sugimoto, C. Expression of two subtypes of human IFN-Alpha in transgenic potato plants. J. Interferon Cytokine Res., 2001, 21, 595-602. (Pubitemid 32911665)
85. Park, Y.; Cheong, H. Expression and production of recombinant human interleukin-2 in potato plants. Protein Expr. Purif., 2002, 25, 160-5. (Pubitemid 36035012)
86. Sawahel, W.A. The production of transgenic potato plants expressing human alpha-interferon using lipofectin-mediated transformation. Cell Mol. Biol. Lett., 2002, 7, 19-29. (Pubitemid 34437061)
87. Gutiérrez-Ortega, A.; Sandoval-Montes, C.; de Olivera-Flores, T.J.; Santos-Argumedo, L.; Gómez-Lim, M.A. Expression of functional interleukin-12 from mouse in transgenic tomato plants. Transgenic Res., 2005, 14, 877-85. (Pubitemid 41706051)
88. Gellerfors, P.; Axelsson, K.; Helander, A.; Johansson, S.; Kenne, L.; Lindqvist, S.; Pavlu, B.; Skottner, A.; Fryklund, L. Isolation and characterization of a glycosylated form of human insulin-like growth factor I produced in Saccharomyces cerevisiae. J. Biol. Chem., 1989, 264, 11444-9. (Pubitemid 19168883)
89. Daniell, H.; Ruiz, G.; Denes, B.; Sandberg, L.; Langridge, W. Optimization of codon composition and regulatory elements for expression of human insulin like growth factor-1 in transgenic chloroplasts and evaluation of structural identity and function. BMC Biotechnol., 2009, 9, 33.
90. Arlen, P.A.; Falconer, R.; Cherukumilli, S.; Cole, A.; Cole, A.M.; Oishi, K.K.; Daniell, H. Field production and functional evaluation of chloroplastderived interferon-Alpha2b. Plant Biotechnol. J., 2007, 5, 511-25. (Pubitemid 46855101)
91. Xie, T.; Qiu, Q.; Zhang, W.; Ning, T.; Yang, W.; Zheng, C.; Wang, C.; Zhu, Y.; Yang, D. A biologically active rhIGF-1 fusion accumulated in transgenic rice seeds can reduce blood glucose in diabetic mice via oral delivery. Peptides, 2008, 29, 1862-70.
92. Song L, Zhao DG, Wu YJ, Li Y. Transient expression of chicken alpha interferon gene in lettuce. J. Zhejiang Univ. Sci. B, 2008, 9, 351-5.
93. Xu, J.; Ge, X.; Dolan, M.C. Towards high-yield production of pharmaceutical proteins with plant cell suspension cultures. Biotechnol. Adv., 2011, 29, 278-99.
94. Kim, N.S.; Kim, T.G.; Jang, Y.S.; Shin, Y.J.; Kwon, T.H.; Yang, M.S. Amylase gene silencing by RNA interference improves recombinant hGMCSF production in rice suspension culture. Plant Mol. Biol., 2008, 68, 369-77.
95. Kim, N.S.; Kim, T.G.; Kim, O.H.; Ko, E.M.; Jang, Y.S.; Jung, E.S.; Kwon, T.H.; Yang, M.S. Improvement of recombinant hGM-CSF production by suppression of cysteine proteinase gene expression using RNA interference in a transgenic rice culture. Plant Mol. Biol., 2008, 68, 263-75.
96. Conley, A.J.; Mohib, K.; Jevnikar, A.M.; Brandle, J.E. Plant recombinant erythropoietin attenuates inflammatory kidney cell injury. Plant Biotechnol. J., 2009, 7, 183-99.
97. Kittur, F.S.; Hung, C.Y.; Darlington, D.E.; Sane, D.C.; Xie, J. NGlycosylation engineering of tobacco plants to produce asialoerythropoietin. Plant Cell Rep., 2012, 31, 1233-43.
98. Wilson, I.B.; Zeleny, R.; Kolarich, D.; Staudacher, E.; Stroop, C.J.; Kamerling, J.P.; Altmann, F. Analysis of Asn-linked glycans from vegetable foodstuffs: widespread occurrence of Lewis a, core alpha1,3-linked fucose and xylose substitutions. Glycobiology, 2001, 11, 261-74. (Pubitemid 32600396)
99. Petruccelli, S.; Otegui, M.S.; Lareu, F.; Tran Dinh, O.; Fitchette, A.C.; Circosta, A.; Rumbo, M.; Bardor, M.; Carcamo, R.; Gomord, V.; Beachy, R.N. A KDEL-Tagged monoclonal antibody is efficiently retained in the endoplasmic reticulum in leaves, but is both partially secreted and sorted to protein storage vacuoles in seeds. Plant Biotechnol. J., 2006, 4, 511-27. (Pubitemid 44267795)
100. Parsons, J.; Altmann, F.; Arrenberg, C.K.; Koprivova, A.; Beike, A.K.; Stemmer, C.; Gorr, G.; Reski, R.; Decker, E.L. Moss-based production of asialo-erythropoietin devoid of Lewis A and other plant-Typical carbohydrate determinants. Plant Biotechnol. J., 2012, 10, 851-61.
101. Koprivova, A.; Stemmer, C.; Altmann, F.; Hoffmann, A.; Kopriva, S.; Gorr, G.; Reski, R.; Decker, E.L. Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans. Plant Biotechnol. J., 2004, 2, 517-23. (Pubitemid 40199428)
102. Ferrer-Miralles, N.; Domingo-Espín, J.; Corchero, J.L.; Vázquez, E.; Villaverde, A. Microbial factories for recombinant pharmaceuticals. Microb. Cell Fact., 2009, 8, 17.
103. Boyhan, D.; Daniell, H. Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and Cpeptide. Plant Biotechnol. J., 2011, 9, 585-98.
104. Leite, A.; Kemper, E.L.; da Silva, M.J.; Luchessi, A.D.; Siloto, R.M.P.; Bonaccorsi, E.D.; El-Dorry, H.F.; Arruda, P. Expression of correctly processed human growth hormone in seeds of transgenic tobacco plants. Mol. Breed., 2000, 6(1), 47-53. (Pubitemid 30118785)
105. Rabindran, S.; Stevenson, N.; Roy, G.; Fedorkin, O.; Skarjinskaia, M.; Ensley, B.; Yusibov, V. Plant-produced human growth hormone shows biological activity in a rat model. Biotechnol. Prog., 2009, 25, 530-4.
106. Cunha, N.B.; Murad, A.M.; Cipriano, T.M.; Araújo, A.C.; Aragao, F.J.; Leite, A.; Vianna, G.R.; McPhee, T.R.; Souza, G.H.; Waters, M.J.; Rech, E.L. Expression of functional recombinant human growth hormone in transgenic soybean seeds. Transgenic Res., 2011, 20, 811-26.
107. Hollak, C.E. An evidence-based review of the potential benefits of taliglucerase alfa in the treatment of patients with Gaucher disease. Core Evid., 2012, 7, 15-20.
108. Shaaltiel, Y.; Bartfeld, D.; Hashmueli, S.; Baum, G.; Brill-Almon, E.; Galili, G.; Dym, O.; Boldin-Adamsky, S.A.; Silman, I.; Sussman, J.L.; Futerman, A.H.; Aviezer, D. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system. Plant Biotechnol. J., 2007, 5, 579-90. (Pubitemid 47196361)
109. Fedosov, S.N.; Laursen, N.B.; Nexø, E.; Moestrup, S.K.; Petersen, T.E.; Jensen, E.; Berglund, L. Human intrinsic factor expressed in the plant Arabidopsis thaliana. Eur. J. Biochem., 2003, 270, 3362-7. (Pubitemid 37020922)
110. Bor, M.V.; Fedosov, S.N.; Laursen, N.B.; Nexø, E. Recombinant human intrinsic factor expressed in plants is suitable for use in measurement of vitamin B12. Clin. Chem., 2003, 49, 2081-3. (Pubitemid 37451785)
111. Hvas, A.M.; Buhl, H.; Laursen, N.B.; Hesse, B.; Berglund, L.; Nexo, E. The effect of recombinant human intrinsic factor on the uptake of vitamin B12 in patients with evident vitamin B12 deficiency. Haematologica, 2006, 91, 805-8. (Pubitemid 44014548)
112. Sijmons, P.C.; Dekker, B.M.; Schrammeijer, B.; Verwoerd, T.C.; van den Elzen, P.J.; Hoekema, A. Production of correctly processed human serum albumin in transgenic plants. Biotechnology (N Y), 1990, 8, 217-21.
113. Farran, I.; Sánchez-Serrano, J.J.; Medina, J.F.; Prieto, J.; Mingo-Castel, A.M. Targeted expression of human serum albumin to potato tubers. Transgenic Res., 2002, 11, 337-46. (Pubitemid 35301745)
114. Fernández-San Millán, A.; Mingo-Castel, A.; Miller, M.; Daniell, H. A chloroplast transgenic approach to hyper-express and purify Human Serum Albumin, a protein highly susceptible to proteolytic degradation. Plant Biotechnol. J., 2003, 1, 71-9.
115. Hood, E.E.; Woodard, S.L.; Horn, M.E. Monoclonal antibody manufacturing in transgenic plants-myths and realities. Curr. Opin. Biotechnol., 2002, 13, 630-5. (Pubitemid 35448068)
116. Stoger, E.; Ma, J.K.; Fischer, R.; Christou, P. Sowing the seeds of success: pharmaceutical proteins from plants. Curr. Opin. Biotechnol., 2005, 16, 167-73.
117. He, Y.; Ning, T.; Xie, T.; Qiu, Q.; Zhang, L.; Sun, Y.; Jiang, D.; Fu, K.; Yin, F.; Zhang, W.; Shen, L.; Wang, H.; Li, J.; Lin, Q.; Li, H.; Zhu, Y.; Yang, D. Large-scale production of functional human serum albumin from transgenic rice seeds. Proc. Natl. Acad. Sci. USA, 2011, 108, 19078-83.
118. Cunha, N.B.; Murad, A.M.; Ramos, G.L.; Maranhao, A.Q.; Brígido, M.M.; Araújo, A.C.; Lacorte, C.; Aragao, F.J.; Covas, D.T.; Fontes, A.M.; Souza, G.H.; Vianna, G.R.; Rech EL. Accumulation of functional recombinant human coagulation factor IX in transgenic soybean seeds. Transgenic Res., 2011, 20, 841-55.
119. Bond, M.; Jankowski, M.; Patel, H.; Karnik, S.; Strang, A.; Xu, B.; Rouse, J.; Koza, S.; Letwin, B.; Steckert, J.; Amphlett, G.; Scoble, H. Biochemical characterization of recombinant factor IX. Semin Hematol., 1998, 35, 11-7. (Pubitemid 28177995)